Ultimovacs Overview
Founded
2011
Status
Public
Employees
17
Stock Symbol
ULTIMO
Investments
1
Share Price
$4.85
(As of Tuesday Closing)
Ultimovacs General Information
Description
Ultimovacs ASA is a Norway based pharmaceutical company involved in developing novel immunotherapies against cancer. Its product candidate is UV1, a peptide-based vaccine inducing T cell responses against the universal cancer antigen telomerase. The company and its proprietary technology is based on preclinical and clinical research on immunotherapies conducted at the Oslo University Hospital.
Contact Information
Primary Industry
Drug Discovery
Other Industries
Biotechnology
Pharmaceuticals
Stock Exchange
OSL
Primary Office
- Ullernchausséen 64
- 0379 Oslo
- Norway
+47 413 00 000
Ultimovacs Stock Performance
(As of Tuesday closing)
| Stock Price | Previous Close | 52 wk Range | Market Cap | Shares | Average Volume | EPS |
|---|---|---|---|---|---|---|
| $4.85 | $4.54 | $2.33 - $8.25 | $135M | 27.9M | 38.3K | -$0.32 |
Ultimovacs Financials Summary
|
In Thousands, USD |
TTM 31-Mar-2020 | FY 2019 31-Dec-2019 | FY 2018 31-Dec-2018 | FY 2017 31-Dec-2017 |
|---|---|---|---|---|
| EV | 43,875 | 78,800 | ||
| Revenue | 0 | 0 | 0 | 0 |
| EBITDA | (8,937) | (7,343) | (6,869) | (3,974) |
| Net Income | (8,499) | (6,948) | (6,788) | (3,970) |
| Total Assets | 42,923 | 54,203 | 21,792 | 21,777 |
| Total Debt | 370 | 411 | 0 | 0 |
Public Fundamental Data provided by Morningstar, Inc.
disclaimer
Ultimovacs Valuation & Funding
| Deal Type | Date | Amount | Valuation/ EBITDA |
Post-Val | Status | Debt |
|---|
This information is available in the PitchBook Platform. To explore Ultimovacs‘s full profile, request access.
Request a free trial
Ultimovacs Executive Team (7)
1 Former Executive
Ultimovacs Board Members (9)
| Name | Representing | Role | Since |
|---|---|---|---|
| 00000 00000000 000000 | Self | Board Member | 000 0000 |
| 00ø00 00000000 | Gjelsten Holding | Board Member | 000 0000 |
| 000000 000ü00000 | Gjelsten Holding | Board Member | 000 0000 |
| 00000 000000000 00 | Self | Board Member | 000 0000 |
| 00000 000000000 | Ultimovacs | Chairman | 000 0000 |
Ultimovacs Investments (1)
| Company Name | Deal Date | Deal Type | Deal Size | Industry | Lead Partner |
|---|---|---|---|---|---|
| 00000000 | 03-Sep-2018 | 0000000000 | 00.000 | Drug Discovery | 0000 0000000 00.0 |
Ready to get started?
Request a free trial
Ultimovacs Subsidiaries (1)
| Company Name | Industry | Location | Founded |
|---|---|---|---|
| 00000000 | Drug Discovery | Uppsala, Sweden | 0000 |